[Role of the nuclear medicine in the treatment of thyroid carcinoma].
D000230:Adenocarcinoma / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000628:therapy; D002291:Carcinoma, Papillary / Q000628:therapy; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013667:Technetium; D013954:Thyroglobulin / Q000097:blood; D013963:Thyroid Hormones / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013667:Technetium; D013954:Thyroglobulin
Die Aufgaben des Nuklearmediziners in der Therapie des Schilddrüsen-Karzinoms.